-
Notifications
You must be signed in to change notification settings - Fork 2
/
Copy pathLepirudin.xml
2761 lines (2761 loc) · 118 KB
/
Lepirudin.xml
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
<drug type="biotech" created="2005-06-13" updated="2018-03-02">
<drugbank-id primary="true">DB00001</drugbank-id>
<drugbank-id>BTD00024</drugbank-id>
<drugbank-id>BIOD00024</drugbank-id>
<name>Lepirudin</name>
<description>Lepirudin is identical to natural hirudin except for substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. It is produced via yeast cells. Bayer ceased the production of lepirudin (Refludan) effective May 31, 2012.</description>
<cas-number>138068-37-8</cas-number>
<unii>Y43GF64R34</unii>
<state>liquid</state>
<groups>
<group>approved</group>
</groups>
<general-references>
<articles>
<article>
<pubmed-id>16244762</pubmed-id>
<citation>Smythe MA, Stephens JL, Koerber JM, Mattson JC: A comparison of lepirudin and argatroban outcomes. Clin Appl Thromb Hemost. 2005 Oct;11(4):371-4.</citation>
</article>
<article>
<pubmed-id>16690967</pubmed-id>
<citation>Tardy B, Lecompte T, Boelhen F, Tardy-Poncet B, Elalamy I, Morange P, Gruel Y, Wolf M, Francois D, Racadot E, Camarasa P, Blouch MT, Nguyen F, Doubine S, Dutrillaux F, Alhenc-Gelas M, Martin-Toutain I, Bauters A, Ffrench P, de Maistre E, Grunebaum L, Mouton C, Huisse MG, Gouault-Heilmann M, Lucke V: Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood. 2006 Sep 1;108(5):1492-6. Epub 2006 May 11.</citation>
</article>
<article>
<pubmed-id>16241940</pubmed-id>
<citation>Lubenow N, Eichler P, Lietz T, Greinacher A: Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. J Thromb Haemost. 2005 Nov;3(11):2428-36.</citation>
</article>
</articles>
<textbooks/>
<links>
<link>
<title>Google books</title>
<url>http://books.google.com/books?id=iadLoXoQkWEC&pg=PA440</url>
</link>
</links>
</general-references>
<synthesis-reference/>
<indication>For the treatment of heparin-induced thrombocytopenia</indication>
<pharmacodynamics>Lepirudin is used to break up clots and to reduce thrombocytopenia. It binds to thrombin and prevents thrombus or clot formation. It is a highly potent, selective, and essentially irreversible inhibitor of thrombin and clot-bond thrombin. Lepirudin requires no cofactor for its anticoagulant action. Lepirudin is a recombinant form of hirudin, an endogenous anticoagulant found in medicinal leeches.</pharmacodynamics>
<mechanism-of-action>Lepirudin forms a stable non-covalent complex with alpha-thrombin, thereby abolishing its ability to cleave fibrinogen and initiate the clotting cascade. The inhibition of thrombin prevents the blood clotting cascade. </mechanism-of-action>
<toxicity>In case of overdose (eg, suggested by excessively high aPTT values) the risk of bleeding is increased.</toxicity>
<metabolism>Lepirudin is thought to be metabolized by release of amino acids via catabolic hydrolysis of the parent drug. However, con-clusive data are not available. About 48% of the administration dose is excreted in the urine which consists of unchanged drug (35%) and other fragments of the parent drug.</metabolism>
<absorption>Bioavailability is 100% following injection.</absorption>
<half-life>Approximately 1.3 hours</half-life>
<protein-binding/>
<route-of-elimination>Lepirudin is thought to be metabolized by release of amino acids via catabolic hydrolysis of the parent drug. About 48% of the administration dose is excreted in the urine which consists of unchanged drug (35%) and other fragments of the parent drug.</route-of-elimination>
<volume-of-distribution>* 12.2 L [Healthy young subjects (n = 18, age 18-60 years)]
* 18.7 L [Healthy elderly subjects (n = 10, age 65-80 years)]
* 18 L [Renally impaired patients (n = 16, creatinine clearance below 80 mL/min)]
* 32.1 L [HIT patients (n = 73)]</volume-of-distribution>
<clearance>* 164 ml/min [Healthy 18-60 yrs]
* 139 ml/min [Healthy 65-80 yrs]
* 61 ml/min [renal impaired]
* 114 ml/min [HIT (Heparin-induced thrombocytopenia)]</clearance>
<classification>
<description/>
<direct-parent>Peptides</direct-parent>
<kingdom>Organic Compounds</kingdom>
<superclass>Organic Acids</superclass>
<class>Carboxylic Acids and Derivatives</class>
<subclass>Amino Acids, Peptides, and Analogues</subclass>
</classification>
<salts/>
<synonyms>
<synonym language="" coder="">Hirudin variant-1</synonym>
<synonym language="" coder="">Lepirudin recombinant</synonym>
</synonyms>
<products>
<product>
<name>Refludan</name>
<labeller>Bayer</labeller>
<ndc-id/>
<ndc-product-code/>
<dpd-id>02240996</dpd-id>
<ema-product-code/>
<ema-ma-number/>
<started-marketing-on>2000-01-31</started-marketing-on>
<ended-marketing-on>2013-07-26</ended-marketing-on>
<dosage-form>Powder, for solution</dosage-form>
<strength>50 mg</strength>
<route>Intravenous</route>
<fda-application-number/>
<generic>false</generic>
<over-the-counter>false</over-the-counter>
<approved>true</approved>
<country>Canada</country>
<source>DPD</source>
</product>
<product>
<name>Refludan</name>
<labeller>Celgene Europe Limited</labeller>
<ndc-id/>
<ndc-product-code/>
<dpd-id/>
<ema-product-code>EMEA/H/C/000122</ema-product-code>
<ema-ma-number>EU/1/97/035/001</ema-ma-number>
<started-marketing-on>1997-03-13</started-marketing-on>
<ended-marketing-on>2012-07-27</ended-marketing-on>
<dosage-form>Injection, solution, concentrate</dosage-form>
<strength>50 mg</strength>
<route>Intravenous</route>
<fda-application-number/>
<generic>false</generic>
<over-the-counter>false</over-the-counter>
<approved>false</approved>
<country>EU</country>
<source>EMA</source>
</product>
<product>
<name>Refludan</name>
<labeller>Celgene Europe Limited</labeller>
<ndc-id/>
<ndc-product-code/>
<dpd-id/>
<ema-product-code>EMEA/H/C/000122</ema-product-code>
<ema-ma-number>EU/1/97/035/002</ema-ma-number>
<started-marketing-on>1997-03-13</started-marketing-on>
<ended-marketing-on>2012-07-27</ended-marketing-on>
<dosage-form>Injection, solution, concentrate</dosage-form>
<strength>50 mg</strength>
<route>Intravenous</route>
<fda-application-number/>
<generic>false</generic>
<over-the-counter>false</over-the-counter>
<approved>false</approved>
<country>EU</country>
<source>EMA</source>
</product>
<product>
<name>Refludan</name>
<labeller>Celgene Europe Limited</labeller>
<ndc-id/>
<ndc-product-code/>
<dpd-id/>
<ema-product-code>EMEA/H/C/000122</ema-product-code>
<ema-ma-number>EU/1/97/035/003</ema-ma-number>
<started-marketing-on>1997-03-13</started-marketing-on>
<ended-marketing-on>2012-07-27</ended-marketing-on>
<dosage-form>Injection, solution, concentrate</dosage-form>
<strength>20 mg</strength>
<route>Intravenous</route>
<fda-application-number/>
<generic>false</generic>
<over-the-counter>false</over-the-counter>
<approved>false</approved>
<country>EU</country>
<source>EMA</source>
</product>
<product>
<name>Refludan</name>
<labeller>Celgene Europe Limited</labeller>
<ndc-id/>
<ndc-product-code/>
<dpd-id/>
<ema-product-code>EMEA/H/C/000122</ema-product-code>
<ema-ma-number>EU/1/97/035/004</ema-ma-number>
<started-marketing-on>1997-03-13</started-marketing-on>
<ended-marketing-on>2012-07-27</ended-marketing-on>
<dosage-form>Injection, solution, concentrate</dosage-form>
<strength>20 mg</strength>
<route>Intravenous</route>
<fda-application-number/>
<generic>false</generic>
<over-the-counter>false</over-the-counter>
<approved>false</approved>
<country>EU</country>
<source>EMA</source>
</product>
</products>
<international-brands/>
<mixtures>
<mixture>
<name>Refludan</name>
<ingredients>Lepirudin</ingredients>
</mixture>
<mixture>
<name>Refludan</name>
<ingredients>Lepirudin</ingredients>
</mixture>
<mixture>
<name>Refludan</name>
<ingredients>Lepirudin</ingredients>
</mixture>
<mixture>
<name>Refludan</name>
<ingredients>Lepirudin</ingredients>
</mixture>
<mixture>
<name>Refludan</name>
<ingredients>Lepirudin</ingredients>
</mixture>
</mixtures>
<packagers>
<packager>
<name>Bayer Healthcare</name>
<url>http://www.bayerhealthcare.com</url>
</packager>
<packager>
<name>Berlex Labs</name>
<url>http://www.berlex.com</url>
</packager>
</packagers>
<manufacturers>
<manufacturer generic="false" url="">Bayer healthcare pharmaceuticals inc</manufacturer>
</manufacturers>
<prices>
<price>
<description>Refludan 50 mg vial</description>
<cost currency="USD">273.19</cost>
<unit>vial</unit>
</price>
</prices>
<categories>
<category>
<category>Amino Acids, Peptides, and Proteins</category>
<mesh-id>D000602</mesh-id>
</category>
<category>
<category>Anti-coagulant</category>
<mesh-id/>
</category>
<category>
<category>Anticoagulants</category>
<mesh-id>D000925</mesh-id>
</category>
<category>
<category>Antithrombin Proteins</category>
<mesh-id>D058833</mesh-id>
</category>
<category>
<category>Antithrombins</category>
<mesh-id>D000991</mesh-id>
</category>
<category>
<category>Blood and Blood Forming Organs</category>
<mesh-id/>
</category>
<category>
<category>Cardiovascular Agents</category>
<mesh-id>D002317</mesh-id>
</category>
<category>
<category>Chemical Actions and Uses</category>
<mesh-id>D020164</mesh-id>
</category>
<category>
<category>Enzyme Inhibitors</category>
<mesh-id>D004791</mesh-id>
</category>
<category>
<category>Fibrin Modulating Agents</category>
<mesh-id>D050299</mesh-id>
</category>
<category>
<category>Fibrinolytic Agents</category>
<mesh-id>D005343</mesh-id>
</category>
<category>
<category>Hematologic Agents</category>
<mesh-id>D006401</mesh-id>
</category>
<category>
<category>Molecular Mechanisms of Pharmacological Action</category>
<mesh-id>D045504</mesh-id>
</category>
<category>
<category>Peptides</category>
<mesh-id>D010455</mesh-id>
</category>
<category>
<category>Pharmacologic Actions</category>
<mesh-id>D020228</mesh-id>
</category>
<category>
<category>Protease Inhibitors</category>
<mesh-id>D011480</mesh-id>
</category>
<category>
<category>Proteins</category>
<mesh-id>D011506</mesh-id>
</category>
<category>
<category>Serine Proteinase Inhibitors</category>
<mesh-id>D015842</mesh-id>
</category>
<category>
<category>Serpins</category>
<mesh-id>D015843</mesh-id>
</category>
<category>
<category>Therapeutic Uses</category>
<mesh-id>D045506</mesh-id>
</category>
</categories>
<affected-organisms>
<affected-organism>Humans and other mammals</affected-organism>
</affected-organisms>
<dosages>
<dosage>
<form>Injection, solution, concentrate</form>
<route>Intravenous</route>
<strength>20 mg</strength>
</dosage>
<dosage>
<form>Injection, solution, concentrate</form>
<route>Intravenous</route>
<strength>50 mg</strength>
</dosage>
<dosage>
<form>Powder, for solution</form>
<route>Intravenous</route>
<strength>50 mg</strength>
</dosage>
</dosages>
<atc-codes>
<atc-code code="B01AE02">
<level code="B01AE">Direct thrombin inhibitors</level>
<level code="B01A">ANTITHROMBOTIC AGENTS</level>
<level code="B01">ANTITHROMBOTIC AGENTS</level>
<level code="B">BLOOD AND BLOOD FORMING ORGANS</level>
</atc-code>
</atc-codes>
<ahfs-codes/>
<pdb-entries/>
<fda-label>//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00001.pdf?1265924858</fda-label>
<msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00001.pdf?1368416245</msds>
<patents>
<patent>
<number>5180668</number>
<country>United States</country>
<approved>1993-01-19</approved>
<expires>2010-01-19</expires>
<pediatric-extension>false</pediatric-extension>
</patent>
</patents>
<food-interactions/>
<drug-interactions>
<drug-interaction>
<drugbank-id>DB00977</drugbank-id>
<name>Ethinyl Estradiol</name>
<description>The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB01357</drugbank-id>
<name>Mestranol</name>
<description>The serum concentration of Mestranol can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00783</drugbank-id>
<name>Estradiol</name>
<description>The serum concentration of Estradiol can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB04574</drugbank-id>
<name>Estrone sulfate</name>
<description>The serum concentration of Estrone sulfate can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB09317</drugbank-id>
<name>Synthetic Conjugated Estrogens, A</name>
<description>The serum concentration of Synthetic Conjugated Estrogens, A can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB09381</drugbank-id>
<name>Estrogens, esterified</name>
<description>The serum concentration of Estrogens, esterified can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00269</drugbank-id>
<name>Chlorotrianisene</name>
<description>The serum concentration of Chlorotrianisene can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00286</drugbank-id>
<name>Conjugated estrogens</name>
<description>The serum concentration of Conjugated estrogens can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB01196</drugbank-id>
<name>Estramustine</name>
<description>The serum concentration of Estramustine can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00890</drugbank-id>
<name>Dienestrol</name>
<description>The serum concentration of Dienestrol can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00255</drugbank-id>
<name>Diethylstilbestrol</name>
<description>The serum concentration of Diethylstilbestrol can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB07931</drugbank-id>
<name>Hexestrol</name>
<description>The serum concentration of Hexestrol can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13143</drugbank-id>
<name>Methallenestril</name>
<description>The serum concentration of Methallenestril can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00091</drugbank-id>
<name>Cyclosporine</name>
<description>The serum concentration of Cyclosporine can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB10532</drugbank-id>
<name>Garlic</name>
<description>The serum concentration of Lepirudin can be decreased when it is combined with Garlic.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00864</drugbank-id>
<name>Tacrolimus</name>
<description>The metabolism of Tacrolimus can be decreased when combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00454</drugbank-id>
<name>Pethidine</name>
<description>The risk or severity of adverse effects can be increased when Lepirudin is combined with Pethidine.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00404</drugbank-id>
<name>Alprazolam</name>
<description>The serum concentration of Alprazolam can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB08873</drugbank-id>
<name>Boceprevir</name>
<description>The serum concentration of Lepirudin can be decreased when it is combined with Boceprevir.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00564</drugbank-id>
<name>Carbamazepine</name>
<description>The metabolism of Lepirudin can be increased when combined with Carbamazepine.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB01211</drugbank-id>
<name>Clarithromycin</name>
<description>The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00705</drugbank-id>
<name>Delavirdine</name>
<description>The serum concentration of Delavirdine can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00655</drugbank-id>
<name>Estrone</name>
<description>Estrone may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB09369</drugbank-id>
<name>Polyestradiol phosphate</name>
<description>Polyestradiol phosphate may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB01645</drugbank-id>
<name>Genistein</name>
<description>Genistein may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB04575</drugbank-id>
<name>Quinestrol</name>
<description>Quinestrol may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB09318</drugbank-id>
<name>Synthetic Conjugated Estrogens, B</name>
<description>Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB11478</drugbank-id>
<name>Zeranol</name>
<description>Zeranol may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB11674</drugbank-id>
<name>Equol</name>
<description>Equol may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB12179</drugbank-id>
<name>Secoisolariciresinol</name>
<description>Secoisolariciresinol may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13182</drugbank-id>
<name>Daidzein</name>
<description>Daidzein may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13386</drugbank-id>
<name>Epimestrol</name>
<description>Epimestrol may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB04573</drugbank-id>
<name>Estriol</name>
<description>Estriol may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB12487</drugbank-id>
<name>Promestriene</name>
<description>Promestriene may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13418</drugbank-id>
<name>Moxestrol</name>
<description>Moxestrol may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13952</drugbank-id>
<name>Estradiol acetate</name>
<description>Estradiol acetate may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13954</drugbank-id>
<name>Estradiol cypionate</name>
<description>Estradiol cypionate may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13956</drugbank-id>
<name>Estradiol valerate</name>
<description>Estradiol valerate may decrease the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB04865</drugbank-id>
<name>Omacetaxine mepesuccinate</name>
<description>The risk or severity of bleeding can be increased when Lepirudin is combined with Omacetaxine mepesuccinate.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB01149</drugbank-id>
<name>Nefazodone</name>
<description>The serum concentration of Nefazodone can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB06692</drugbank-id>
<name>Aprotinin</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Aprotinin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13943</drugbank-id>
<name>Testosterone cypionate</name>
<description>The therapeutic efficacy of Lepirudin can be increased when used in combination with Testosterone cypionate.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13944</drugbank-id>
<name>Testosterone enanthate</name>
<description>The therapeutic efficacy of Lepirudin can be increased when used in combination with Testosterone enanthate.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB01431</drugbank-id>
<name>Allylestrenol</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Allylestrenol.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00294</drugbank-id>
<name>Etonogestrel</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Etonogestrel.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00603</drugbank-id>
<name>Medroxyprogesterone acetate</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Medroxyprogesterone acetate.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00396</drugbank-id>
<name>Progesterone</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Progesterone.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00717</drugbank-id>
<name>Norethisterone</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Norethisterone.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB06789</drugbank-id>
<name>Hydroxyprogesterone caproate</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Hydroxyprogesterone caproate.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00304</drugbank-id>
<name>Desogestrel</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Desogestrel.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00378</drugbank-id>
<name>Dydrogesterone</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Dydrogesterone.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB06730</drugbank-id>
<name>Gestodene</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Gestodene.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB11372</drugbank-id>
<name>Altrenogest</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Altrenogest.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB11619</drugbank-id>
<name>Gestrinone</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Gestrinone.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB09124</drugbank-id>
<name>Medrogestone</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Medrogestone.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB11636</drugbank-id>
<name>Nomegestrol</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Nomegestrol.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13230</drugbank-id>
<name>Gestonorone</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Gestonorone.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13533</drugbank-id>
<name>Methylestrenolone</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Methylestrenolone.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13563</drugbank-id>
<name>Norgestrienone</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Norgestrienone.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13602</drugbank-id>
<name>Promegestone</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Promegestone.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13857</drugbank-id>
<name>Demegestone</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Demegestone.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00351</drugbank-id>
<name>Megestrol acetate</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Megestrol acetate.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00367</drugbank-id>
<name>Levonorgestrel</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Levonorgestrel.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB09123</drugbank-id>
<name>Dienogest</name>
<description>The therapeutic efficacy of Lepirudin can be decreased when used in combination with Dienogest.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13946</drugbank-id>
<name>Testosterone undecanoate</name>
<description>The therapeutic efficacy of Lepirudin can be increased when used in combination with Testosterone undecanoate.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB08931</drugbank-id>
<name>Riociguat</name>
<description>The serum concentration of Riociguat can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00203</drugbank-id>
<name>Sildenafil</name>
<description>The serum concentration of Sildenafil can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB06287</drugbank-id>
<name>Temsirolimus</name>
<description>The risk or severity of adverse effects can be increased when Lepirudin is combined with Temsirolimus.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00343</drugbank-id>
<name>Diltiazem</name>
<description>The metabolism of Diltiazem can be decreased when combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00661</drugbank-id>
<name>Verapamil</name>
<description>The metabolism of Verapamil can be decreased when combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00686</drugbank-id>
<name>Pentosan Polysulfate</name>
<description>Pentosan Polysulfate may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00321</drugbank-id>
<name>Amitriptyline</name>
<description>The serum concentration of Amitriptyline can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00344</drugbank-id>
<name>Protriptyline</name>
<description>The serum concentration of Protriptyline can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00458</drugbank-id>
<name>Imipramine</name>
<description>The serum concentration of Imipramine can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00540</drugbank-id>
<name>Nortriptyline</name>
<description>The serum concentration of Nortriptyline can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00726</drugbank-id>
<name>Trimipramine</name>
<description>The serum concentration of Trimipramine can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB01142</drugbank-id>
<name>Doxepin</name>
<description>The serum concentration of Doxepin can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB01151</drugbank-id>
<name>Desipramine</name>
<description>The serum concentration of Desipramine can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB01242</drugbank-id>
<name>Clomipramine</name>
<description>The serum concentration of Clomipramine can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00370</drugbank-id>
<name>Mirtazapine</name>
<description>The serum concentration of Mirtazapine can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00924</drugbank-id>
<name>Cyclobenzaprine</name>
<description>The serum concentration of Cyclobenzaprine can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB04836</drugbank-id>
<name>Amineptine</name>
<description>The serum concentration of Amineptine can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB06678</drugbank-id>
<name>Esmirtazapine</name>
<description>The serum concentration of Esmirtazapine can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB09167</drugbank-id>
<name>Dosulepin</name>
<description>The serum concentration of Dosulepin can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB09289</drugbank-id>
<name>Tianeptine</name>
<description>The serum concentration of Tianeptine can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB12930</drugbank-id>
<name>Opipramol</name>
<description>The serum concentration of Opipramol can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13225</drugbank-id>
<name>Dibenzepin</name>
<description>The serum concentration of Dibenzepin can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13411</drugbank-id>
<name>Lofepramine</name>
<description>The serum concentration of Lofepramine can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB13496</drugbank-id>
<name>Iprindole</name>
<description>The serum concentration of Iprindole can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00543</drugbank-id>
<name>Amoxapine</name>
<description>The serum concentration of Amoxapine can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB01048</drugbank-id>
<name>Abacavir</name>
<description>The serum concentration of Abacavir can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00531</drugbank-id>
<name>Cyclophosphamide</name>
<description>The risk or severity of adverse effects can be increased when Lepirudin is combined with Cyclophosphamide.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00390</drugbank-id>
<name>Digoxin</name>
<description>The serum concentration of Digoxin can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00109</drugbank-id>
<name>Enfuvirtide</name>
<description>The serum concentration of Enfuvirtide can be increased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB06414</drugbank-id>
<name>Etravirine</name>
<description>The serum concentration of Etravirine can be decreased when it is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB01254</drugbank-id>
<name>Dasatinib</name>
<description>Dasatinib may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB01609</drugbank-id>
<name>Deferasirox</name>
<description>The risk or severity of adverse effects can be increased when Lepirudin is combined with Deferasirox.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB03619</drugbank-id>
<name>Deoxycholic Acid</name>
<description>The risk or severity of adverse effects can be increased when Lepirudin is combined with Deoxycholic Acid.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00078</drugbank-id>
<name>Ibritumomab tiuxetan</name>
<description>The risk or severity of adverse effects can be increased when Lepirudin is combined with Ibritumomab tiuxetan.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB09053</drugbank-id>
<name>Ibrutinib</name>
<description>The risk or severity of adverse effects can be increased when Ibrutinib is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB09079</drugbank-id>
<name>Nintedanib</name>
<description>The risk or severity of adverse effects can be increased when Lepirudin is combined with Nintedanib.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB08935</drugbank-id>
<name>Obinutuzumab</name>
<description>The risk or severity of adverse effects can be increased when Lepirudin is combined with Obinutuzumab.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00048</drugbank-id>
<name>Collagenase clostridium histolyticum</name>
<description>The risk or severity of adverse effects can be increased when Lepirudin is combined with Collagenase clostridium histolyticum.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB06206</drugbank-id>
<name>Sugammadex</name>
<description>Sugammadex may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB09211</drugbank-id>
<name>Limaprost</name>
<description>The risk or severity of adverse effects can be increased when Limaprost is combined with Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB09070</drugbank-id>
<name>Tibolone</name>
<description>Tibolone may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00465</drugbank-id>
<name>Ketorolac</name>
<description>Ketorolac may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00586</drugbank-id>
<name>Diclofenac</name>
<description>Diclofenac may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00712</drugbank-id>
<name>Flurbiprofen</name>
<description>Flurbiprofen may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00963</drugbank-id>
<name>Bromfenac</name>
<description>Bromfenac may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB06802</drugbank-id>
<name>Nepafenac</name>
<description>Nepafenac may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00005</drugbank-id>
<name>Etanercept</name>
<description>Etanercept may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00179</drugbank-id>
<name>Masoprocol</name>
<description>Masoprocol may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00210</drugbank-id>
<name>Adapalene</name>
<description>Adapalene may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00244</drugbank-id>
<name>Mesalazine</name>
<description>Mesalazine may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00328</drugbank-id>
<name>Indomethacin</name>
<description>Indomethacin may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00337</drugbank-id>
<name>Pimecrolimus</name>
<description>Pimecrolimus may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00461</drugbank-id>
<name>Nabumetone</name>
<description>Nabumetone may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00469</drugbank-id>
<name>Tenoxicam</name>
<description>Tenoxicam may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00482</drugbank-id>
<name>Celecoxib</name>
<description>Celecoxib may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00500</drugbank-id>
<name>Tolmetin</name>
<description>Tolmetin may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00533</drugbank-id>
<name>Rofecoxib</name>
<description>Rofecoxib may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00554</drugbank-id>
<name>Piroxicam</name>
<description>Piroxicam may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00573</drugbank-id>
<name>Fenoprofen</name>
<description>Fenoprofen may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00580</drugbank-id>
<name>Valdecoxib</name>
<description>Valdecoxib may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00605</drugbank-id>
<name>Sulindac</name>
<description>Sulindac may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00608</drugbank-id>
<name>Chloroquine</name>
<description>Chloroquine may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00688</drugbank-id>
<name>Mycophenolate mofetil</name>
<description>Mycophenolate mofetil may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00735</drugbank-id>
<name>Naftifine</name>
<description>Naftifine may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00744</drugbank-id>
<name>Zileuton</name>
<description>Zileuton may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00749</drugbank-id>
<name>Etodolac</name>
<description>Etodolac may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00768</drugbank-id>
<name>Olopatadine</name>
<description>Olopatadine may increase the anticoagulant activities of Lepirudin.</description>
</drug-interaction>
<drug-interaction>
<drugbank-id>DB00784</drugbank-id>
<name>Mefenamic acid</name>
<description>Mefenamic acid may increase the anticoagulant activities of Lepirudin.</description>